Nancy Valente is EVP, Chief Development Officer of Xencor Inc.
Person profile
Roles
Xencor
EVP, Chief Development Officer
Myovant Sciences
Director
Address
Brisbane, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 May 23 | XNCR Xencor | Common Stock | Grant | Acquire A | No | No | 0 | 39,296 | 0.00 | 39,296 |
1 May 23 | XNCR Xencor | Stock Options Common Stock | Grant | Acquire A | No | No | 27.07 | 235,778 | 6.38 mm | 235,778 |
10 Mar 23 | MYOV Myovant Sciences | Common Shares | Sale back to company | Dispose D | No | No | 0 | 3,673 | 0.00 | 0 |
10 Mar 23 | MYOV Myovant Sciences | Stock Options Common Shares | Sale back to company | Dispose D | No | No | 22.71 | 36,892 | 837.82 k | 0 |
26 Oct 22 | MYOV Myovant Sciences | Common Shares | Grant | Acquire A | No | No | 0 | 9,859 | 0.00 | 9,859 |